385 related articles for article (PubMed ID: 28657654)
1. Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.
Wang S; Yang F; Petyuk VA; Shukla AK; Monroe ME; Gritsenko MA; Rodland KD; Smith RD; Qian WJ; Gong CX; Liu T
J Pathol; 2017 Sep; 243(1):78-88. PubMed ID: 28657654
[TBL] [Abstract][Full Text] [Related]
2. Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.
Skorobogatko YV; Deuso J; Adolf-Bryfogle J; Nowak MG; Gong Y; Lippa CF; Vosseller K
Amino Acids; 2011 Mar; 40(3):765-79. PubMed ID: 20563614
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy for global mapping of O-GlcNAc proteins and peptides using selective enzymatic deglycosylation, HILIC enrichment and mass spectrometry identification.
Shen B; Zhang W; Shi Z; Tian F; Deng Y; Sun C; Wang G; Qin W; Qian X
Talanta; 2017 Jul; 169():195-202. PubMed ID: 28411811
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.
Thompson JW; Sorum AW; Hsieh-Wilson LC
Biochemistry; 2018 Jul; 57(27):4010-4018. PubMed ID: 29936833
[TBL] [Abstract][Full Text] [Related]
5. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
Pinho TS; Correia SC; Perry G; Ambrósio AF; Moreira PI
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2048-2059. PubMed ID: 30412792
[TBL] [Abstract][Full Text] [Related]
6. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.
Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD
Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741
[TBL] [Abstract][Full Text] [Related]
7. Interplay between protein glycosylation pathways in Alzheimer's disease.
Frenkel-Pinter M; Shmueli MD; Raz C; Yanku M; Zilberzwige S; Gazit E; Segal D
Sci Adv; 2017 Sep; 3(9):e1601576. PubMed ID: 28929132
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins.
Deracinois B; Camoin L; Lambert M; Boyer JB; Dupont E; Bastide B; Cieniewski-Bernard C
J Proteomics; 2018 Aug; 186():83-97. PubMed ID: 30016717
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Park J; Lai MKP; Arumugam TV; Jo DG
Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis.
Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L
Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
Chun YS; Kwon OH; Chung S
Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of O-GlcNAcylation in combination with isobaric tag labeling and chemoenzymatic enrichment.
Tsumoto H; Akimoto Y; Endo T; Miura Y
Bioorg Med Chem Lett; 2017 Nov; 27(22):5022-5026. PubMed ID: 29029932
[TBL] [Abstract][Full Text] [Related]
14. Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse.
Trinidad JC; Barkan DT; Gulledge BF; Thalhammer A; Sali A; Schoepfer R; Burlingame AL
Mol Cell Proteomics; 2012 Aug; 11(8):215-29. PubMed ID: 22645316
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
Gong CX; Liu F; Iqbal K
Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
[TBL] [Abstract][Full Text] [Related]
16. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
[TBL] [Abstract][Full Text] [Related]
17. A Novel Quantitative Mass Spectrometry Platform for Determining Protein O-GlcNAcylation Dynamics.
Wang X; Yuan ZF; Fan J; Karch KR; Ball LE; Denu JM; Garcia BA
Mol Cell Proteomics; 2016 Jul; 15(7):2462-75. PubMed ID: 27114449
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
[TBL] [Abstract][Full Text] [Related]
20. Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases.
Huynh VN; Wang S; Ouyang X; Wani WY; Johnson MS; Chacko BK; Jegga AG; Qian WJ; Chatham JC; Darley-Usmar VM; Zhang J
Front Aging; 2021; 2():757801. PubMed ID: 35822049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
